From the Journals

Few Childhood Cancer Survivors Get Recommended Screenings


 

Survivorship Care Plans

Low screening rates may result from a lack of awareness about screening recommendations and the negative long-term effects of cancer treatments, the study authors wrote. Cancer survivors, caregivers, family physicians, specialists, and survivor support groups can share the responsibility of spreading awareness and adhering to guidelines, they noted. In some cases, a survivorship care plan (SCP) may help.

“SCPs are intended to improve adherence by providing follow-up information and facilitating the transition from cancer treatment to survivorship and from pediatric to adult care,” Adam Yan, MD, a staff oncologist and oncology informatics lead at the Hospital for Sick Children in Toronto, told this news organization.

Dr. Yan, who wasn’t involved with this study, has researched surveillance adherence for secondary cancers and cardiac dysfunction among childhood cancer survivors. He and his colleagues found that screening rates were typically low among survivors who faced high risks for cardiac dysfunction and breast, colorectal, or skin cancers.

However, having a survivorship care plan seemed to help, and survivors treated after 1990 were more likely to have an SCP.

“SCP possession by high-risk survivors was associated with increased breast, skin, and cardiac surveillance,” he said. “It is uncertain whether SCP possession leads to adherence or whether SCP possession is a marker of survivors who are focused on their health and thus likely to adhere to preventive health practices, including surveillance.”

The study was funded by the Canadian Institutes of Health Research and ICES, which receives support from the Ontario Ministry of Health and the Ministry of Long-Term Care. Dr. Shuldiner received a Canadian Institutes of Health Research Health System Impact Postdoctoral Fellowship in support of the work. Dr. Yan disclosed no relevant financial relationships.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

CT Poses Risk for Malignant Hematopathies Among Children
MDedge Hematology and Oncology
Long-Term Follow-Up Emphasizes HPV Vaccination Importance
MDedge Hematology and Oncology
Unleashing Our Immune Response to Quash Cancer
MDedge Hematology and Oncology
Democratic Lawmakers Press Pfizer on Chemotherapy Drug Shortages
MDedge Hematology and Oncology
New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?
MDedge Hematology and Oncology
FDA Removes Harmful Chemicals From Food Packaging
MDedge Hematology and Oncology
Pfizer Antibody-Drug Conjugate Picks Up Pediatric ALL Indication
MDedge Hematology and Oncology
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
MDedge Hematology and Oncology
New Drug Approvals Are the Wrong Metric for Cancer Policy
MDedge Hematology and Oncology
Most Cancer Trial Centers Located Closer to White, Affluent Populations
MDedge Hematology and Oncology